Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-20-008471
Filing Date
2020-04-02
Accepted
2020-04-02 17:28:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea120370-424b4_therapixbio.htm 424B4 1364343
2 GRAPHIC image_001.jpg GRAPHIC 29351
  Complete submission text file 0001213900-20-008471.txt   1405942
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-236175 | Film No.: 20770352
SIC: 2834 Pharmaceutical Preparations